Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Nov 1.

Published in final edited form as: Urology. 2022 Aug 9;169:58–64. doi: 10.1016/j.urology.2022.07.045

Figure 2. — Symptom Severity scores at four study time-points (Epidemiology and Phenotyping Study Baseline and 1-year visits, Extension (EXT) phase, and Symptom Pattern Study (SPS) phase) stratified by 1-year symptom profiles (improved, stable, worse) (n=163). Mean (SE) scores shown were estimated from multi-phase mixed effects models, adjusted for baseline symptom severity. A. Pelvic Pain Severity scores, B. Urinary Symptom Severity scores.

Figure 2. — Symptom Severity scores at four study time-points (Epidemiology and Phenotyping Study Baseline and 1-year visits, Extension (EXT) phase, and Symptom Pattern Study (SPS) phase) stratified by 1-year symptom profiles (improved, stable, worse) (n=163). Mean (SE) scores shown were estimated from multi-phase mixed effects models, adjusted for baseline symptom severity. A. Pelvic Pain Severity scores, B. Urinary Symptom Severity scores.